{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:09:33Z","timestamp":1761217773877},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,5,17]],"date-time":"2015-05-17T00:00:00Z","timestamp":1431820800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s13277-015-3493-0","type":"journal-article","created":{"date-parts":[[2015,5,16]],"date-time":"2015-05-16T15:42:10Z","timestamp":1431790930000},"page":"8127-8136","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Differential expression and alternative splicing of cell cycle genes in imatinib-treated K562 cells"],"prefix":"10.1007","volume":"36","author":[{"given":"Jing","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Mei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Hua","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Zhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,17]]},"reference":[{"issue":"4","key":"3493_CR1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0959-8049(99)00046-5","volume":"35","author":"R Weinberg","year":"1999","unstructured":"Weinberg R, Lundberg A. Control of the cell cycle and apoptosis. Eur J Cancer. 1999;35(4):531\u20139.","journal-title":"Eur J Cancer"},{"issue":"3","key":"3493_CR2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2184.2003.00266.x","volume":"36","author":"K Vermeulen","year":"2003","unstructured":"Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 2003;36(3):131\u201349.","journal-title":"Cell Prolif"},{"issue":"10","key":"3493_CR3","doi-asserted-by":"crossref","first-page":"e1462","DOI":"10.1038\/cddis.2014.420","volume":"5","author":"S Senese","year":"2014","unstructured":"Senese S, Lo Y, Huang D, Zangle T, Gholkar A, Robert L, et al. Chemical dissection of the cell cycle: probes for cell biology and anti-cancer drug development. Cell Death Dis. 2014;5(10):e1462.","journal-title":"Cell Death Dis"},{"key":"3493_CR4","doi-asserted-by":"crossref","unstructured":"Alexander A, Keyomarsi K. Exploiting cell cycle pathways in cancer therapy: new (and old) targets and potential strategies. Nuclear Signaling Pathways and Targeting Transcription in Cancer. Springer; 2014; 337\u201372.","DOI":"10.1007\/978-1-4614-8039-6_14"},{"issue":"26","key":"3493_CR5","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1038\/sj.onc.1206498","volume":"22","author":"N Nishimura","year":"2003","unstructured":"Nishimura N, Furukawa Y, Sutheesophon K, Nakamura M, Kishi K, Okuda K, et al. Suppression of ARG kinase activity by Sti571 induces cell cycle arrest through up-regulation of CDK inhibitor p18\/Ink4c. Oncogene. 2003;22(26):4074\u201382.","journal-title":"Oncogene"},{"issue":"3A","key":"3493_CR6","first-page":"1445","volume":"24","author":"A Roussidis","year":"2004","unstructured":"Roussidis A, Mitropoulou T, Theocharis A, Kiamouris C, Papadopoulos S, Kletsas D, et al. Sti571 as a potent inhibitor of growth and invasiveness of human epithelial breast cancer cells. Anticancer Res. 2004;24(3A):1445\u20138.","journal-title":"Anticancer Res"},{"issue":"10","key":"3493_CR7","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/sj.bjc.6602592","volume":"92","author":"O Uziel","year":"2005","unstructured":"Uziel O, Fenig E, Nordenberg J, Beery E, Reshef H, Sandbank J, et al. Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines. Br J Cancer. 2005;92(10):1881\u201391.","journal-title":"Br J Cancer"},{"issue":"13","key":"3493_CR8","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1182\/blood-2004-04-1433","volume":"104","author":"T Yin","year":"2004","unstructured":"Yin T, Wu Y-L, Sun H-P, Sun G-L, Du Y-Z, Wang K-K, et al. Combined effects of As4s4 and Imatinib on chronic myeloid leukemia cells and BCR-ABL oncoprotein. Blood. 2004;104(13):4219\u201325.","journal-title":"Blood"},{"issue":"6","key":"3493_CR9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000338941","volume":"35","author":"J Liu","year":"2012","unstructured":"Liu J, Huang B, Xiao Y, Xiong H-M, Li J, Feng D-Q, et al. Aberrant expression of splicing factors in newly diagnosed acute myeloid leukemia. Onkologie. 2012;35(6):335\u201340.","journal-title":"Onkologie"},{"issue":"6","key":"3493_CR10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nsmb.2040","volume":"18","author":"P Prinos","year":"2011","unstructured":"Prinos P, Garneau D, Lucier J-F, Gendron D, Couture S, Boivin M, et al. Alternative splicing of SYK regulates mitosis and cell survival. Nat Struct Mol Biol. 2011;18(6):673\u20139.","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"3493_CR11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molcel.2011.03.014","volume":"42","author":"E-Y Ahn","year":"2011","unstructured":"Ahn E-Y, DeKelver RC, Lo M-C, Nguyen TA, Matsuura S, Boyapati A, et al. Son controls cell-cycle progression by coordinated regulation of RNA splicing. Mol Cell. 2011;42(2):185\u201398.","journal-title":"Mol Cell"},{"issue":"5","key":"3493_CR12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis Jr","year":"2003","unstructured":"Dennis Jr G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. David: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4(5):3.","journal-title":"Genome Biol"},{"issue":"1","key":"3493_CR13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1423-0127-16-46","volume":"16","author":"L-M Yin","year":"2009","unstructured":"Yin L-M, Jiang G-H, Wang Y, Wang Y, Liu Y-Y, Jin W-R, et al. Use of serial analysis of gene expression to reveal the specific regulation of gene expression profile in asthmatic rats treated by acupuncture. J Biomed Sci. 2009;16(1):46.","journal-title":"J Biomed Sci"},{"issue":"5","key":"3493_CR14","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1182\/blood.V96.5.1933","volume":"96","author":"T Jonuleit","year":"2000","unstructured":"Jonuleit T, van der Kuip H, Miething C, Michels H, Hallek M, Duyster J, et al. BCR-ABL kinase down-regulates cyclin-dependent kinase inhibitor P27 in human and murine cell lines. Blood. 2000;96(5):1933\u20139.","journal-title":"Blood"},{"issue":"1","key":"3493_CR15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/1471-2105-9-432","volume":"9","author":"T-Y Chang","year":"2008","unstructured":"Chang T-Y, Li Y-Y, Jen C-H, Yang T-P, Lin C-H, Hsu M-T, et al. Easyexon\u2014a java-based Gui tool for processing and visualization of affymetrix exon array data. BMC Bioinformatics. 2008;9(1):432.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"3493_CR16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.cellbio.13.1.261","volume":"13","author":"DO Morgan","year":"1997","unstructured":"Morgan DO. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol. 1997;13(1):261\u201391.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"4","key":"3493_CR17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0092-8674(94)90543-6","volume":"79","author":"T Hunter","year":"1994","unstructured":"Hunter T, Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell. 1994;79(4):573\u201382.","journal-title":"Cell"},{"issue":"4","key":"3493_CR18","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S1471-4914(02)02308-0","volume":"8","author":"EA Sausville","year":"2002","unstructured":"Sausville EA. Complexities in the development of cyclin-dependent kinase inhibitor drugs. Trends Mol Med. 2002;8(4):S32\u2013S7.","journal-title":"Trends Mol Med"},{"issue":"12","key":"3493_CR19","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1517\/13543784.9.12.2903","volume":"9","author":"LR Kelland","year":"2000","unstructured":"Kelland LR. Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status. Expert Opin Investig Drugs. 2000;9(12):2903\u201311.","journal-title":"Expert Opin Investig Drugs"},{"issue":"4","key":"3493_CR20","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1182\/blood-2005-06-2318","volume":"107","author":"Y Du","year":"2006","unstructured":"Du Y, Wang K, Fang H, Li J, Xiao D, Zheng P, et al. Coordination of intrinsic, extrinsic, and endoplasmic reticulum-mediated apoptosis by Imatinib mesylate combined with arsenic trioxide in chronic myeloid leukemia. Blood. 2006;107(4):1582\u201390.","journal-title":"Blood"},{"issue":"11\/12","key":"3493_CR21","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1515\/znc-2006-11-1219","volume":"61","author":"I Majsterek","year":"2006","unstructured":"Majsterek I, Arabski M, Czechowska A, Pytel D, Morawiec Z, Morawiec-Bajda A, et al. Imatinib (Sti571) inhibits DNA repair in human leukemia oncogenic tyrosine kinase-expressing cells. Zeitschrift fur Naturforschung C. 2006;61(11\/12):896.","journal-title":"Zeitschrift fur Naturforschung C"},{"issue":"10","key":"3493_CR22","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/00001813-200211000-00009","volume":"13","author":"J Blasiak","year":"2002","unstructured":"Blasiak J, Gloc E, Pertynski T, Drzewoski J. DNA damage and repair in BCR\/ABL-expressing cells after combined action of idarubicin, Sti571 and amifostine. Anti-Cancer Drugs. 2002;13(10):1055\u201360.","journal-title":"Anti-Cancer Drugs"},{"issue":"6","key":"3493_CR23","doi-asserted-by":"crossref","first-page":"e18643","DOI":"10.1371\/journal.pone.0018643","volume":"6","author":"J-G Chang","year":"2011","unstructured":"Chang J-G, Yang D-M, Chang W-H, Chow L-P, Chan W-L, Lin H-H, et al. Small molecule amiloride modulates oncogenic Rna alternative splicing to devitalize human cancer cells. PLoS One. 2011;6(6):e18643.","journal-title":"PLoS One"},{"issue":"7","key":"3493_CR24","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1091\/mbc.7.7.1083","volume":"7","author":"K Lundgren","year":"1996","unstructured":"Lundgren K, Allan S, Urushiyama S, Tani T, Ohshima Y, Frendewey D, et al. A connection between pre-mRNA splicing and the cell cycle in fission yeast: cdc28+ is allelic with prp8+ and encodes an RNA-dependent ATPase\/helicase. Mol Biol Cell. 1996;7(7):1083\u201394.","journal-title":"Mol Biol Cell"},{"issue":"3","key":"3493_CR25","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1128\/MCB.22.3.801-815.2002","volume":"22","author":"CG Burns","year":"2002","unstructured":"Burns CG, Ohi R, Mehta S, O\u2019Toole ET, Winey M, Clark TA, et al. Removal of a single \u0391-tubulin gene intron suppresses cell cycle arrest phenotypes of splicing factor mutations in saccharomyces cerevisiae. Mol Cell Biol. 2002;22(3):801\u201315.","journal-title":"Mol Cell Biol"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3493-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-3493-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3493-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T08:23:38Z","timestamp":1599035018000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-3493-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,17]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["3493"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-3493-0","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,17]]}}}